29 June 2025
Learn how pharmaceutical tariffs could raise U.S. drug costs by nearly $51 billion and impact American consumers.
29 June 2025
Examine the realities of Australia's crumbling universal healthcare system and how funding problems are affecting patients nationwide.
29 June 2025
Antibiotic resistance claims lives in South African neonates, creating a critical public health crisis for vulnerable infants.
29 June 2025
The latest SAMRC study uncovers severe underreporting of HIV deaths in SA, revealing gaps that demand urgent public health attention.
29 June 2025
Discover the alarming predictions concerning PEPFAR funding cuts: 65,000 additional AIDS deaths and 300,000 new infections by 2028.
29 June 2025
NHI causes uncertainty with its ambitious goals in South Africa. Analyse the challenges to health financing reforms and public funding.
29 June 2025
Adcock Ingram's Urizone receives legal protection as the court halts Cipla's Furizome, citing trademark infringement.
29 June 2025
Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.
29 June 2025
Health Minister Aaron Motsoaledi discusses the NHI advertising campaign designed to address misinformation and support health efforts.
29 June 2025
Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.
29 June 2025
Read about the Clicks interim results that reveal a 13.2% rise in headline earnings per share and significant market achievements.
29 June 2025
Get insights on the Trump drug price executive order and how it may reshape timelines for drug price negotiations.